StockData
Shoulder Innovations, Inc. logo

Shoulder Innovations, Inc. (SI) stock

SINYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3052% above fair value
$20.69−0.39 (-1.85%)

Close on Nov 13, 2026Market cap $430.74MP/E –Yield –

Earnings

Shoulder Innovations's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 9, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
$16.20M
+37.3% on a year earlier
EPS, Q3 FY2026
-$0.34
-$0.64 a year earlier
Latest guidance
Issued
Nov 5, 2026 · 1 item

Quarterly results

Revenue and earnings per share from each of Shoulder Innovations's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 9, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 5, 2026after the close$16.20M+37.3%-$0.34Release
Q2 FY2026ended Jun 30, 2026Aug 6, 2026after the close$17.20M+56.4%-$0.49Release
Q1 FY2026ended Mar 31, 2026May 13, 2026after the close$16.70M–-$0.41Release
Q4 FY2025ended Dec 31, 2025Mar 10, 2026after the close$14.40M–-$0.38Release
Q3 FY2025ended Sep 30, 2025Nov 12, 2025before the open$11.80M–-$0.64Release
Q2 FY2025ended Jun 30, 2025Sep 9, 2025before the open$11.00M–-$165.53Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Shoulder Innovations's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
growth over full year 2025 net revenueFY2026+42% – +46%+37% – +44%RaisedAug 6, 2026
net revenueFY2026$68.00M – $70.00M–NewNov 5, 2026
net revenueFY2026$67.00M – $69.00M$65.00M – $68.00MRaisedAug 6, 2026

Guidance history

Every forecast Shoulder Innovations put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 5, 2026net revenueFY2026$68.00M – $70.00MNew
Aug 6, 2026net revenueFY2026$67.00M – $69.00MRaised
Aug 6, 2026growth over full year 2025 net revenueFY2026+42% – +46%Raised
May 13, 2026net revenueFY2026$65.00M – $68.00MRaised
May 13, 2026growth over full year 2025 net revenueFY2026+37% – +44%New
Mar 10, 2026net revenueFY2026$62.00M – $65.00MNew
Nov 12, 2025revenueFY2025$45.00M – $46.00MNew
Nov 12, 2025revenue growthFY2025+42% – +45%New
Sep 9, 2025revenueFY2025$42.00M – $44.00MNew
Sep 9, 2025revenueFY2025+33% – +39%New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Shoulder Innovations filed with the SEC as exhibits to Form 8-K or 6-K

  1. Shoulder Innovations Reports Third Quarter 2026 Financial Results and Raises Full Year Outlook
    Results
  2. Shoulder Innovations Initiates Commercial Launch of the InSet® Go
    Update
  3. Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer
    Update
  4. Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook
    Results
  5. Shoulder Innovations Announces Closing of up to $50 Million Credit Facility
    Update
  6. Shoulder Innovations Reports First Quarter 2026 Financial Results and Raises Full Year Outlook
    Results
  7. Shoulder Innovations Initiates Full Commercial Launch of the InSet™ I-135RFX Humeral Stem
    Update
  8. Shoulder Innovations Reports Fourth Quarter and Full Year 2025 Financial Results
    Results
  9. Shoulder Innovations Appoints MedTech Veteran Drew Hykes to Board of Directors
    Update
  10. Shoulder Innovations Announces Strategic Partnership with INS to Introduce a Robotic Platform for Shoulder Arthroplasty
    Update
  11. Shoulder Innovations Reports Third Quarter 2025 Financial Results and Increases Full-Year Revenue Guidance
    Results
  12. Third Quarter 2025 Earnings Call
    Results
  13. Shoulder Innovations Reports Second Quarter 2025 Financial Results
    Results

See a number that looks wrong?